BLUSD:PA:PA- (USD)

ETF | Others |

Last Closing

USD 11.728

Change

+0.03 (+0.22)%

Market Cap

N/A

Volume

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.05 (-0.10%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-1.00 (-0.20%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-1.08 (-0.30%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

-0.03 (-0.09%)

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.11 (+0.44%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-0.35 (-0.08%)

USD 7.99B
WLD:PA Lyxor UCITS MSCI World D-EUR

-0.34 (-0.10%)

USD 7.49B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.02 (-0.36%)

USD 7.42B
HHH:PA HSBC S&P 500 UCITS ETF

-0.09 (-0.18%)

USD 7.22B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-0.09 (-0.11%)

USD 5.38B

ETFs Containing BLUSD:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.65% 74% C 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.65% 74% C 66% D+
Trailing 12 Months  
Capital Gain 2.11% 34% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.11% 30% F 50% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.65% 40% F 53% F
Dividend Return 5.65% 38% F 27% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.22% 70% C- 44% F
Risk Adjusted Return 61.26% 40% F 36% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.